Neuronetics, Inc. (STIM) Stock Analysis
A live, multi-source view of Neuronetics, Inc. (STIM): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Neuronetics, Inc.
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare · Industry: Medical Devices · United States · 658 employees · neurostar.com/neuronetics
Key statistics · as of 2026-09-06
As of 2026-09-06, Neuronetics, Inc. (STIM) had a market capitalization of $219.4M (forward -8.5) and a beta of 1.17; the shares traded in a 52-week range of $0.80 – $3.71 (-14.5% over the year).
- Market cap
- $219.4M
- Enterprise value
- $290.6M
- Forward P/E
- -8.5
- Price / book
- 12.31
- EPS (trailing)
- $-0.43
- EPS (forward)
- $-0.34
- Payout ratio
- 0.0%
- 52-week range
- $0.80 – $3.71
- 52-week change
- -14.5%
- Beta
- 1.17
- Average volume
- 2.1M
- Shares outstanding
- 76.2M
- Short % of float
- 19.65%
- Profit margin
- -19.6%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-10
In RapidTradeView’s 2026-09-10 scan of the US universe, Neuronetics, Inc. (STIM) last closed at $3.04 (the last completed close before that scan).
Technicals at the scan: RSI 62 (neutral territory), price +1.3% versus its 20-day average, 20-day versus 50-day average spread +28.8%, MACD histogram -0.05.
Sentiment inputs: StockTwits 79% bullish; analyst consensus score 83/100.
Next scheduled company event: in 54 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of STIM; corporate insiders filed 1 buy and 0 sells (1 filer, latest disclosure 2026-08-17). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Jorey Chernett (1B/0S). Who is trading what
RapidTradeView pick record
STIM has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Neuronetics, Inc. (STIM) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell STIM.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.